Deborah Dunsire - 01 Jun 2024 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role: Director
Signature: /s/ Todd Rosenthal, as attorney-in-fact
Issuer symbol: SYRS
Transactions as of: 01 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2024, 16:42:09 UTC
Previous filing: 09 Jun 2023
Next filing: 04 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SYRS	Common Stock	Options Exercise		+4,000	+50%		12,000	01 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SYRS	Restricted Stock Units	Options Exercise	$0	-4,000	-100%	$0.000000^*	0	01 Jun 2024	Common Stock	4,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award.
F2	Each RSU represents the contingent right to receive one share of the issuer's common stock.
F3	These RSUs vested in their entirety on the first anniversary of the date of grant of the award.